M&A Corner
Cigna Ends Acquisition Talks with Humana, Announces $10B Share Repurchase Plan18 Dec 2023
Cigna halts acquisition of Humana due to price disagreements, facing antitrust issues in a potential $140B merger. Opting for a... Continue Reading
|
ConcertAI Acquires CancerLinQ to Expand Real-World Data and AI Solutions for Cancer Care18 Dec 2023
ConcertAI has acquired CancerLinQ, enhancing its real-world data platform with a $250 million investment. This move aims to revolutionize cancer... Continue Reading
|
AbbVie Continues Buying Spree with $8.7B Cerevel Acquisition to Bolster Neuro11 Dec 2023
Revolution Medicines, Inc. (Nasdaq: RVMD), a cancer-focused company in clinical stages, has finalized its acquisition of EQRx, Inc. The merger... Continue Reading
|
SciSparc Provides Updates Regarding the Non-Binding Letter of Intent to Acquire Leading Vehicle Importer Company in Israel11 Dec 2023
SciSparc Ltd. (Nasdaq: SPRC), a clinical-stage pharmaceutical firm dedicated to central nervous system disorder treatments, revealed progress on negotiations after... Continue Reading
|
Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers11 Dec 2023
Cosmos Health Inc. (NASDAQ:COSM) finalized an agreement with Cloudpharm PC to obtain patent rights (PCT/EP2023/071865) focusing on repurposing an existing... Continue Reading
|
Fountain Life Acquires LifeOmic to Optimize Preventative Care11 Dec 2023
Fountain Life, a leader in advanced diagnostics and proactive healthcare, has acquired LifeOmic, specializing in health data technology and precision... Continue Reading
|
Medical Technology Innovator Thornhill Medical’s MOVES® SLC™ is acquired for United States Marine Corp En Route Care Modernization and added to Authorized Medical Allowance List (AMAL) 64711 Dec 2023
Thornhill Medical proudly announces the US Marine Corps’ acquisition of its MOVES® SLC™ integrated life support technology, bolstering En Route... Continue Reading
|
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline11 Dec 2023
AbbVie Inc. (NYSE: ABBV) has entered into a definitive agreement to acquire Cerevel Therapeutics (NASDAQ: CERE), enhancing its neuroscience portfolio... Continue Reading
|
Kaneka Acquires Japan Medical Device Technology11 Dec 2023
Kaneka Corporation (TOKYO:4118), based in Minato-ku, Tokyo, acquired all shares of Japan Medical Device Technology Co., Ltd. (JMDT), headquartered in... Continue Reading
|
Danaher Completes Acquisition of Abcam11 Dec 2023
Danaher Corporation (NYSE:DHR) finalized its acquisition of Abcam plc (NASDAQ:ABCM) for $24.00 per share in cash on December 6, 2023.... Continue Reading
|